RPS6KB1 and breast cancer: Regarding this hypothesis, we have shown that metformin failed to suppress basal tumor growth in 4T1-bearing mice, but suppressed both growth and phosphorylated-mTOR/S6K levels in 4T1 mammary tumors, but only when co-administered with a DPP-4 inhibitor [29].